Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
life sciences
national blog main
san francisco blog main
avapritinib
blueprint medicines
boston top stories
clinical trials
deals
eli lilly
fda
genentech
investing
medullary thyroid cancer
national top stories
non-small cell lung cancer
pralsetinib
roche
san francisco top stories
selpercatinib
thyroid cancer
akouos
astellas pharmaceuticals
california institute for biomedical research
cancer
cancer drugs
capmatinib
cstone pharmaceuticals
decibel therapeutics
europe blog main
europe top stories
european medicines agency
fisogatinib
flatiron health
frequency therapeutics
gastrointestinal stromal tumors
harvard university
hearing loss
What
drug
fda
3
×
medicines
3
×
approval
blueprint
cancer
ret
address
affects
americans
approved
approves
candidate
carries
certain
currently
date
designed
developing
frequency
genetic
hearing
ipo
latest
loss
marketing
meds
millions
muscle
pact
pass
plans
regenerative
regulatory
review
roche
signature
signatures
targeted
targeting
Language
unset
Current search:
medicines
×
fda
×
boston
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds